Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sid Gilman

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 10, 2012
Heterogeneity of cholinergic denervation in Parkinson's disease without dementiaNicolaas I Bohnen, Martijn L T M Müller, Vikas Kotagal, et al.
Acta Neuropathologica Communications|November 21, 2013
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's diseaseLauren D Stutzbach, Sharon X Xie, Adam C Naj, et al.
The Lancet. Neurology|December 16, 2014
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trialWerner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, et al.
Annals of Neurology|July 11, 2006
Unexpected abundance of pathological tau in progressive supranuclear palsy white matterVictoria Zhukareva, Sonali Joyce, Teresa Schuck, et al.
Medgenmed : Medscape General Medicine|August 24, 2006
Rosuvastatin: an independent analysis of risks and benefitsDouglas P Zipes, Nathan J Zvaifler, Richard J Glassock, et al.
The Lancet. Neurology|February 11, 2014
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trialPhillip A Low, David Robertson, Sid Gilman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2004
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)Gregor K Wenning, François Tison, Klaus Seppi, et al.
The Lancet. Neurology|May 31, 2015
Natural history of multiple system atrophy in the USA: a prospective cohort studyPhillip A Low, Stephen G Reich, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophySusanne May, Sid Gilman, B Brooke Sowell, et al.
Archives of Neurology|June 10, 2009
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failureAxel Lipp, Paola Sandroni, J Eric Ahlskog, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 10, 2012
Heterogeneity of cholinergic denervation in Parkinson's disease without dementiaNicolaas I Bohnen, Martijn L T M Müller, Vikas Kotagal, et al.
Acta Neuropathologica Communications|November 21, 2013
The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's diseaseLauren D Stutzbach, Sharon X Xie, Adam C Naj, et al.
The Lancet. Neurology|December 16, 2014
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trialWerner Poewe, Klaus Seppi, Cheryl J Fitzer-Attas, et al.
Annals of Neurology|July 11, 2006
Unexpected abundance of pathological tau in progressive supranuclear palsy white matterVictoria Zhukareva, Sonali Joyce, Teresa Schuck, et al.
Medgenmed : Medscape General Medicine|August 24, 2006
Rosuvastatin: an independent analysis of risks and benefitsDouglas P Zipes, Nathan J Zvaifler, Richard J Glassock, et al.
The Lancet. Neurology|February 11, 2014
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trialPhillip A Low, David Robertson, Sid Gilman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 29, 2004
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)Gregor K Wenning, François Tison, Klaus Seppi, et al.
The Lancet. Neurology|May 31, 2015
Natural history of multiple system atrophy in the USA: a prospective cohort studyPhillip A Low, Stephen G Reich, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophySusanne May, Sid Gilman, B Brooke Sowell, et al.
Archives of Neurology|June 10, 2009
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failureAxel Lipp, Paola Sandroni, J Eric Ahlskog, et al.
Pageof 6